594 results on '"Durif F"'
Search Results
2. Efficacité de la neuromodulation sacrée chez le patient parkinsonien
3. Troubles du contrôle des impulsions dans la maladie de Parkinson : spectre clinique, physiopathologie et prise en charge
4. Does REM sleep behavior disorder change in the progression of Parkinson’s disease?
5. A case–control study investigating food addiction in Parkinson patients
6. Utilité des chambres calorimétriques pour mesurer les changements des dépenses énergétiques chez les patients atteints de la maladie de Parkinson
7. French consensus procedure for assessing cognitive function in Parkinson's disease
8. Personalized mapping of the deep brain with a white matter attenuated inversion recovery (WAIR) sequence at 1.5-tesla: Experience based on a series of 156 patients
9. Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease
10. Facteurs associés à la densité osseuse mesurée par pQCT et DXA dans la maladie de Parkinson
11. Usefulness of calorimetric chambers for measuring changes of energy expenditure in Parkinson disease patients
12. Validation of a non-motor fluctuations questionnaire in Parkinson's disease
13. Screening hypersexuality in Parkinson's disease in everyday practice
14. Complications chirurgicales de la stimulation cérébrale profonde : expérience clinique à propos de 184 cas
15. Psycho-sensory modalities of visual hallucinations and illusions in Parkinson's disease
16. Nigrostriatal dopaminergic depletion produces orofacial static mechanical allodynia
17. La maladie de Parkinson idiopathique : une maladie métabolique ?
18. Increased risk of impulse control symptoms in Parkinsonʼs disease with REM sleep behaviour disorder
19. Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson
20. Emmanuel Chabrier en Espagne
21. Manifestations psychopathologiques dans la maladie de Gilles de la Tourette
22. L’apport de la psychologie et des neurosciences cognitives dans l’exploration des substrats anatomiques et fonctionnels impliqués dans le syndrome de Gilles de la Tourette
23. Données actuelles sur la physiopathologie du syndrome de Gilles de la Tourette
24. Clinique du syndrome de Gilles de la Tourette chez l’adulte
25. Étude Précoce : évaluation d’un autoquestionnaire de dépistage et prise en charge précoces des fluctuations dans la maladie de Parkinson
26. Comparison between automatic and visual scoring methods of muscle tone during rapid eye movement sleep in Parkinsonʼs disease: P727
27. Association between impulsive-compulsive behaviors and REM sleep behavior disorder in Parkinsonʼs disease: a video-polysomnographic study: P725
28. Sensitivity and specificity of two screening questionnaires for REM sleep behaviour disorder and relationship with REM sleep without atonia in patients with Parkinsonʼs disease: 267
29. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study
30. Sensitivity and specificity of the “REM sleep behavior disorder-single-question screen” (RBD-1Q) in Parkinson’s disease: EP3271
31. Prevalence of hypo- and hyperdopaminergic behaviors in PD patients and impact on quality of life: OS2215
32. OPTIPUMP study: impact of apomorphine pump therapy at 6 months on 145 parkinsonian patients’ quality of life. A multicentre French observational prospective study: OS2214
33. Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease; long term follow-up
34. Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?
35. Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study
36. Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up
37. Major eosinophilia induced by subcutaneous apomorphine infusion: four cases
38. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinsonʼs disease with a sexual dimorphism
39. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia
40. Stimulation sous-thalamique dans la maladie de Parkinson sévère: Étude de la localisation des contacts effectifs
41. Atteinte diffuse du deuxième motoneurone révélant une méningite carcinomateuse
42. Direct Stereotactic MRI Location in the Globus Pallidus for Chronic Stimulation in Parkinson's Disease
43. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinsonʼs disease in the European population
44. Large-scale screening of the Gaucherʼs disease-related glucocerebrosidase gene in Europeans with Parkinsonʼs disease
45. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study
46. REM sleep behavior disorder changes in the progression of Parkinson's disease: a longitudinal study
47. Parkinsonʼs disease-related LRRK2 G2019S mutation results from independent mutational events in humans
48. New electrophysiological mapping combined with MRI in parkinsonianʼs subthalamic region
49. Sodium Valproate for Slowing Down Disease Progression in Progressive Supranuclear Palsy. A French Multicenter Randomized Placebo-controlled Study
50. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.